Stuart Goldberg, M.D., an oncologist at the John Theurer Cancer Center and chief medical officer of Cota, weighs in on how advances in cancer care should be balanced against the need to get health care costs under control.
Dr. Stuart Goldberg weighs in on historic FDA approval of blockbuster leukemnia drug
My Health eNews
- Choose the news you want from more than two dozen topics.
- Medically-reviewed health news drawn from 350+ sources, delivered monthly to your inbox.
- Your username and password ensure your personalized news is delivered only to you.